Correlation Between Appili Therapeutics and Cardiol Therapeutics

Can any of the company-specific risk be diversified away by investing in both Appili Therapeutics and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Appili Therapeutics and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Appili Therapeutics and Cardiol Therapeutics Class, you can compare the effects of market volatilities on Appili Therapeutics and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Appili Therapeutics with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Appili Therapeutics and Cardiol Therapeutics.

Diversification Opportunities for Appili Therapeutics and Cardiol Therapeutics

-0.71

Correlation Coefficient

Appili Therapeutics  Cardiol Therapeutics

Pay attention - limited upside

The 3 months correlation between Appili and Cardiol is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Appili Therapeutics and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and Appili Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Appili Therapeutics are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of Appili Therapeutics i.e., Appili Therapeutics and Cardiol Therapeutics go up and down completely randomly.

Pair Corralation between Appili Therapeutics and Cardiol Therapeutics

Assuming the 90 days trading horizon Appili Therapeutics is expected to under-perform the Cardiol Therapeutics. In addition to that, Appili Therapeutics is 3.17 times more volatile than Cardiol Therapeutics Class. It trades about -0.02 of its total potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about 0.09 per unit of volatility. If you would invest  136.00  in Cardiol Therapeutics Class on April 22, 2025 and sell it today you would earn a total of  25.00  from holding Cardiol Therapeutics Class or generate 18.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Appili Therapeutics  vs.  Cardiol Therapeutics Class

Appili Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Appili Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in August 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Cardiol Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cardiol Therapeutics Class are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Cardiol Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Appili Therapeutics and Cardiol Therapeutics

The main advantage of trading using opposite Appili Therapeutics and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Appili Therapeutics position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.

The idea behind Appili Therapeutics and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.